PLAY PODCASTS
Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes
Episode 143

Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

Listen as expert faculty answer audience questions on personalized management of patients with MDS from a live symposium during ASH 2022.

Decera Clinical Education Oncology Podcast · Rami Komrokji MD, María Díez Campelo MD PhD, Amer Zeidan MBBS MHS

February 17, 202321m 59s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this podcast, Rami Komrokji, MD; María Díez Campelo, MD, PhD; and Amer Zeidan, MBBS, MHS answer questions from an audience of healthcare professionals on topics related to personalized management of myelodysplastic syndromes including:  

  • Practical use of the Molecular International Prognostic Scoring System  
  • Mutational targets and other treatments in ongoing clinical trials
  • Prophylaxis with venetoclax therapy
  • Best practices for bone marrow transplant, including induction and salvage regimens
  • Treatment options for hypoplastic myelodysplastic syndromes

Presenters:
Rami Komrokji, MD
Professor
Department of Oncologic Sciences
University of South Florida  
Vice Chair
Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida

María Díez Campelo, MD, PhD
Associate Professor
Department of Medicine
School of Medicine
University of Salamanca
Hematologist
Department of Hematology
University Hospital of Salamanca
Salamanca, Spain

Amer Zeidan, MBBS, MHS
Associate Professor, Internal Medicine
Hematology
Leader, Leukemia and Myeloid Disease Aligned Research Team (DART)
Director, Hematology Early Therapeutics Research
Yale Cancer Center and Smilow Cancer Hospital
Yale University School of Medicine
New Haven, Connecticut

Link to full program, including downloadable slidesets, expert commentaries, and on-demand webcast:
http://bit.ly/3YXgKK3

 

 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

antibioticlag-3ngsimmune checkpoint inhibitionwho classificationring sideroblastshigher-risktp53 mutationhypomethylating agenttpoidh inhibitorlenalidomideeltrombopagverona trialicc classificationtigitcyclosporinevenetoclaxhmamyelodysplastic syndromesiron chelationhypoplastic mdssabatolimabacute myeloid leukemiasf3b1 mutationmagrolimabipss-mapr246donor lymphocyte infusionmolecular international prognostic scoring systematgsintra-rev trialrisk stratificationtim-3salvage therapyazacitidinetransfusionluspaterceptamlantithymocyte globulinmdscommands trialstem cell transplantnext generation sequencingthrombopoietin receptor agonisthigh-blastinduction therapy